SPOTLIGHT -
Expert hematologist/oncologists review key datasets in leukemia presented at the ASH 2022 Annual Meeting.
EP. 1: Preview: Updates from ASH 2022
Sameem Abedin, MD announces an upcoming program wherein expert hematologist/oncologists will review key datasets in leukemia presented at the ASH 2022 Annual Meeting.
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Both Gastric and Breast HER2 Scoring Algorithms Applicable in mCRC Testing
Encorafenib Plus Cetuximab and Chemotherapy Demonstrates Safety, Efficacy in BRAF V600E–Mutant mCRC